Geelong Centre for Emerging Infectious Diseases (GCEID)
The Geelong Centre for Emerging Infectious Diseases (GCEID) has a “one health” approach that delivers innovative research outcomes and solutions to the risks posed by emerging infectious diseases.
GCEID combines specialised research facilities and highly skilled staff to combat infectious diseases through a collaborative, multidisciplinary partnership between Barwon Health, Deakin University and CSIRO – Australian Centre for Disease Preparedness.
GCEID is led by Professor Soren Alexandersen, one of the world’s leading experts on “one health” – the multidisciplinary approach to managing infectious diseases in people, animals and the environment.
The priority of GCEID activity is to conduct and translate emerging infectious diseases research from the bench to the environment or bedside.
In addition to the work done at the core facilities, GCEID is also an important hub for facilitating collaboration and coordination of swift research on emerging infectious diseases, including diagnostics, vaccines, therapeutics, and epidemiology.
|Barwon Health||CSIRO –|
|University of Melbourne||University of Copenhagen|
|NHMRC CRE APPRAISE||Scolexia Animal Health Consultancy|
- Professor Soren Alexandersen, Centre Director
- Dr Jason Hodge, Laboratory Manager
- Dr Anthony Chamings, Post-Doctoral researcher
- Jessy Vibin, PhD: Metagenomics of Viruses in Australian Wild Birds.
- Tarka Raj Bhatta, PhD: Detection and characterisation of animal influenza and other viruses.
- Aseel Al-Araji, PhD: Detection and characterisation of bacterial antimicrobial resistance genes using molecular methods.
- Berta Blanch Lazaro, PhD: Disease ecology, genomics and immunology of beak and feather disease virus in crimson rosellas.
- NHMRC - Australian Partnership (for) Preparedness Research on InfectiouS (disease) Emergencies (APPRISE):2016-2022
- ARC - Genomic diversity, tolerance and ecology of wildlife disease:2018-2021
Support Our Research
Participate in a Clinical Trial
To find out about Clinical Trials currently underway at Barwon Health, click here.
Clinical trials require ongoing investment and there are several ways to support this amazing work.
You can make a donation today and contribute to an item on our research wish list, consider a bequest in your will, or establish a lasting legacy fund in your name. No matter what size, your philanthropic support with deliver an immediate impact.
To donate now or for more information and further discuss your support, please contact the Barwon Health Foundation.
- A Minion mini-sequencer to do rapid, few samples, next generation sequencing for clinicians.
- Upgrade to lab equipment to facilitate higher throughput and to expand capacity to do recombinant protein work.
- Significant expansion of lab equipment to facilitate emergency diagnostic back-up function including quality assurance, validation, certification and equipment redundancy.
Last Modified: Monday, 26 April 2021